STOCK TITAN
  1. Home
  2. News
  3. MOTS

Motus GI to Release Fourth Quarter and Full Year 2021 Results and Provide a Business Update on March 29

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

FORT LAUDERDALE, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its fourth quarter and full year financial results on Tuesday, March 29, 2022, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.

Conference Call and Webcast
Date and Time: Tuesday, March 29that 4:30 p.m. ET
Domestic: 877-407-0792
International: 201-689-8263
Passcode: 13727501
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1533147&tp_key=9ce5b7fd09
   

A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.

About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.

For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.

Investor Contact:
Troy Williams
LifeSci Advisors
(518) 221-0106
twilliams@lifesciadvisors.com


Stock MOTS logo
MOTUS GI HOLDINGS INC

OTC:MOTS

MOTS Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

MOTS Latest News

Mar 18, 2024
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Feb 29, 2024
EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer
Feb 22, 2024
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
Feb 21, 2024
Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract
Feb 16, 2024
Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders

MOTS Stock Data

435.11k
4.97M
1.12%
4.71%
0.45%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
FT. LAUDERDALE

About MOTS

motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe.